Infectious complications of biological and small molecule targeted immunomodulatory therapies
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …
immunosuppression. We have moved from relying on broadly active traditional medications …
Antibody-independent functions of B cells during viral infections
The humoral immune response and antibody-mediated functions of B cells during viral
infections are well described. However, we have limited understanding of antibody …
infections are well described. However, we have limited understanding of antibody …
[HTML][HTML] Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency …
IM Otani, HK Lehman, AM Jongco, LR Tsao… - Journal of Allergy and …, 2022 - Elsevier
Secondary hypogammaglobulinemia (SHG) is characterized by reduced immunoglobulin
levels due to acquired causes of decreased antibody production or increased antibody loss …
levels due to acquired causes of decreased antibody production or increased antibody loss …
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind …
Background Rituximab could be an effective treatment for childhood-onset, complicated,
frequently relapsing nephrotic syndrome (FRNS) and steroid-dependent nephrotic …
frequently relapsing nephrotic syndrome (FRNS) and steroid-dependent nephrotic …
Chemotherapy‐induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study
C Hsu, HH Tsou, SJ Lin, MC Wang, M Yao… - …, 2014 - Wiley Online Library
Fatal hepatitis B virus (HBV) reactivation in lymphoma patients with “resolved” HBV infection
(hepatitis B surface antigen [HBsAg] negative and hepatitis B core antibody [anti‐HBc] …
(hepatitis B surface antigen [HBsAg] negative and hepatitis B core antibody [anti‐HBc] …
[HTML][HTML] ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious …
Background The present review is part of the ESCMID Study Group for Infections in
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …
Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and …
Treatment of neuromyelitis optica spectrum disorder: acute, preventive, and symptomatic
Opinion statement Neuromyelitis optica spectrum disorder (NMOSD) is a rare, autoimmune
disease of the central nervous system that primarily attacks the optic nerves and spinal cord …
disease of the central nervous system that primarily attacks the optic nerves and spinal cord …
Serologic vaccination response after solid organ transplantation: a systematic review
Background Infectious diseases after solid organ transplantation (SOT) are one of the major
complications in transplantation medicine. Vaccination-based prevention is desirable, but …
complications in transplantation medicine. Vaccination-based prevention is desirable, but …
Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab
EAA Christou, G Giardino, A Worth… - … Reviews of Immunology, 2017 - Taylor & Francis
Rituximab (RTX) is a monoclonal antibody against CD20, commonly used in the treatment of
hematological malignancies and autoimmune diseases. The use of RTX is related to the …
hematological malignancies and autoimmune diseases. The use of RTX is related to the …
Hypogammaglobulinaemia after rituximab treatment—incidence and outcomes
M Makatsori, S Kiani-Alikhan, AL Manson… - … Journal of Medicine, 2014 - academic.oup.com
Background: Rituximab, a chimeric monoclonal antibody against CD20, is increasingly used
in the treatment of B-cell lymphomas and autoimmune conditions. Transient peripheral B …
in the treatment of B-cell lymphomas and autoimmune conditions. Transient peripheral B …